sPD-L1, released by cancer cells in truncated form, seems to be involved in immunosuppression but can also affect the efficacy of many treatment types, such as chemotherapy, radiotherapy, and immunotherapy, including PD-L1 blockade therapy [37]. This evidence concerns the gene SPDL1 and cancer.